Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-26

Clinical Trial Update: Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing budesonide capsules to mesalazine granules in active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • Mesalazine (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED